Live Breaking News & Updates on Pharmacoepidemiology Asia Pacific Unit

Stay updated with breaking news from Pharmacoepidemiology asia pacific unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Genomicare Biotechnology: GenomiCare Biotechnology Appoints Dr. Shusen Liu as Chief Medical Officer

Dr. Liu will lead real world data (RWD) strategy and growth of global biopharma company partnershipsHAVERFORD, Pa., Jan. 20, 2022 (GLOBE NEWSWIRE) GenomiCare Biotechnology, a leader in precision medicine ....

United States , Qiang Xu , Kostenloser Wertpapierhandel , Pharmacoepidemiology Asia Pacific , Shusen Liu , Shanghai Medical University , Fudan University , Digital China Health , Care Biotechnology , Chief Medical , Genomicare Biotechnology , Chief Medical Officer , Real World Evidence , Sanofi China , Pharmacoepidemiology Asia Pacific Unit , Vice President , Chief Medical Evidence Officer ,

Investegate |Genomicare Biotechnology Announcements | Genomicare Biotechnology: GenomiCare Biotechnology Appoints Dr. Shusen Liu as Chief Medical Officer

Investegate announcements from Genomicare Biotechnology, GenomiCare Biotechnology Appoints Dr. Shusen Liu as Chief Medical Officer ....

United States , Qiang Xu , Pharmacoepidemiology Asia Pacific , Shusen Liu , Shanghai Medical University , Fudan University , Digital China Health , Genomicare Biotechnology Appoints , Chief Medical , Care Biotechnology , Genomicare Biotechnology , Chief Medical Officer , Real World Evidence , Sanofi China , Pharmacoepidemiology Asia Pacific Unit , Vice President , Chief Medical Evidence Officer , Investegate Announcements , Investegate Company Announcements , Genomicare Biotechnology , Lobenewswire And Globenewswire ,

GenomiCare Biotechnology Appoints Dr. Shusen Liu as Chief Medical Officer

Dr. Liu will lead real world data strategy and growth of global biopharma company partnershipsHAVERFORD, Pa., Jan. 20, 2022 GenomiCare Biotechnology, a leader in precision medicine of Chinese. ....

Qiang Xu , Pharmacoepidemiology Asia Pacific , Shusen Liu , Shanghai Medical University , Fudan University , Digital China Health , Care Biotechnology , Chief Medical , Genomicare Biotechnology , Chief Medical Officer , Real World Evidence , Sanofi China , Pharmacoepidemiology Asia Pacific Unit , Vice President , Chief Medical Evidence Officer ,